# U3 Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/u3-pharma

- Industry: Pharmaceuticals
- Headquarters: Germany
- Website: www.u3pharma.com
- Total disclosed funding: $53M
- Latest round: Series C (May 23, 2006)
- Investors on record: 9

## About

U3 Pharma GmbH an biotechnology firm is a leader in targeted cancer drug development.

## Funding rounds

- Series C, May 23, 2006, $34M — Alta Partners, Atlas Venture, Andera Partners, EQT Life Sciences, SG Growth Capital
- Series B, Sep 15, 2003, $15M — Atlas Venture, Rothschild Ventures, Biomedical Sciences Investment Fund
- Series A, Oct 1, 2001, $4.5M — Alta Partners, BioM, Medicis Capital

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A, Series C
- BioM (https://capitalatlas.ai/funds/biom) — Series A
- Medicis Capital — Series A
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B, Series C
- Rothschild Ventures (https://capitalatlas.ai/funds/rothschild-ventures) — Series B
- Biomedical Sciences Investment Fund — Series B
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series C
- EQT Life Sciences (https://capitalatlas.ai/funds/eqt-life-sciences) — Series C
- SG Growth Capital (https://capitalatlas.ai/funds/sg-growth-capital) — Series C
